JC
FRTX

JBF Capital’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

JBF Capital’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-295,000
Closed -$286K – 79
2023
Q3 		$286K Buy
+295,000
New +$209K 0.06% 54

Other funds holding FRTX

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

JBF Capital's FRTX Position: Q4 2023 in Review

JBF Capital sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2023, closing a stake of 295,000 shares — an estimated $286K sold.

JBF Capital first reported a position in FRTX in Q3 2023 and held it in 1 quarter. The position peaked at $286K in Q3 2023. 1 fund tracked by Wall St. Rank holds FRTX as of Q4 2023.

  • JBF Capital reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • JBF Capital sold 295,000 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $286K.
  • JBF Capital first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • JBF Capital's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $286K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2023.

Based on JBF Capital's 13F filing for Q4 2023, filed 13 Feb 2024.